All stocks
GRANULES
Mid CapGranules India · Pharma
₹892.9
+4.57% today
Market Cap
₹14,000 Cr
CMP
₹892.9
52W High
₹1,109.8
52W Low
₹576.7
P/E
28.2
P/B
3.8
ROCE
16.8%
Div Yield
1.53%
Peer comparison
6 companies · Pharma and nearest by size. Current company highlighted — click a header to sort.
| Company | CMP | MCap (Cr) | P/E | P/B | ROCE | ROE | D/E | Sales 3Y | Profit 3Y | OPM | Div Yld |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | ₹1,945 | 4,45,000 | 38.2 | 6.4 | 18.9% | 16.8% | 0.04 | +16.6% | +22.4% | 24.1% | 0.76% |
| LUPIN | ₹2,363.5 | 92,000 | 34.2 | 5.1 | 18.2% | 16.4% | 0.12 | +16.8% | +19.3% | 23.8% | 0.85% |
| AUROPHARMA | ₹1,658 | 78,000 | 21.8 | 2.6 | 14.1% | 12.8% | 0.18 | +14.2% | +11.4% | 18.4% | 1.13% |
| GRANULES | ₹873.85 | 14,000 | 28.2 | 3.8 | 16.8% | 14.1% | 0.32 | +16% | +18.5% | 21.2% | 1.53% |
| FINEORG | ₹5,162.1 | 14,000 | 42.8 | 8.4 | 26.1% | 20.8% | 0.02 | +23.5% | +22.4% | 32.1% | 0.66% |
| JYOTHYLAB | ₹206.47 | 14,000 | 34.2 | 6.1 | 22.4% | 18.2% | 0.02 | +21.9% | +21.4% | 27.4% | 1.32% |
Quarterly results
Last 8 quarters (₹ Cr unless noted)
| Quarter | Revenue | Op Profit | OPM | Other Inc | Interest | Dep | PBT | Tax | Net Profit | EPS | QoQ | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q3 FY25 | 529 | 116 | 21.9% | 9 | 4 | 14 | 107 | 27 | 81 | 5.04 | — | — |
| Q4 FY25 | 560 | 128 | 22.9% | 4 | 4 | 11 | 117 | 26 | 91 | 5.65 | +12.3% | — |
| Q1 FY26 | 562 | 125 | 22.3% | 3 | 5 | 20 | 104 | 23 | 80 | 5.01 | -12.1% | — |
| Q2 FY26 | 572 | 129 | 22.6% | 11 | 5 | 19 | 116 | 27 | 89 | 5.57 | +11.3% | — |
| Q3 FY26 | 600 | 132 | 22.1% | 6 | 3 | 20 | 114 | 25 | 89 | 5.56 | +0% | +9.9% |
| Q4 FY26 | 630 | 141 | 22.4% | 4 | 7 | 14 | 124 | 30 | 94 | 5.88 | +5.6% | +3.3% |
| Q1 FY27 | 668 | 155 | 23.2% | 8 | 7 | 21 | 135 | 32 | 102 | 6.4 | +8.5% | +27.5% |
| Q2 FY27 | 685 | 157 | 22.9% | 11 | 4 | 22 | 142 | 34 | 108 | 6.74 | +5.9% | +21.3% |
Profit & Loss — Annual
Last 4 years (₹ Cr)
| Year | Revenue | Op Profit | OPM | Net Profit | EPS | Tax Rate | Sales Growth | Profit Growth |
|---|---|---|---|---|---|---|---|---|
| FY23 | 1,989 | 416 | 20.9% | 281 | 17.55 | 25.3% | — | — |
| FY24 | 2,307 | 498 | 21.6% | 319 | 19.92 | 25.9% | +16% | +13.5% |
| FY25 | 2,644 | 577 | 21.8% | 392 | 24.46 | 24.1% | +14.6% | +22.9% |
| FY26 | 3,108 | 660 | 21.2% | 467 | 29.13 | 23.4% | +17.5% | +19.1% |
Balance sheet
Last 8 quarters (₹ Cr)
| Quarter | Share Capital | Reserves | Borrowings | Other Liab | Fixed Assets | CWIP | Investments | Other Assets | Total |
|---|---|---|---|---|---|---|---|---|---|
| Q3 FY25 | 184 | 3,180 | 1,268 | 814 | 1,980 | 284 | 1,200 | 1,982 | 5,446 |
| Q4 FY25 | 184 | 3,270 | 1,086 | 945 | 2,214 | 307 | 1,265 | 1,698 | 5,485 |
| Q1 FY26 | 184 | 3,328 | 1,079 | 891 | 2,160 | 312 | 1,049 | 1,961 | 5,482 |
| Q2 FY26 | 184 | 3,398 | 1,203 | 943 | 1,991 | 283 | 1,075 | 2,379 | 5,727 |
| Q3 FY26 | 184 | 3,480 | 1,293 | 1,004 | 2,047 | 292 | 1,113 | 2,509 | 5,960 |
| Q4 FY26 | 184 | 3,557 | 1,119 | 892 | 2,240 | 260 | 1,059 | 2,192 | 5,751 |
| Q1 FY27 | 184 | 3,657 | 1,159 | 979 | 2,286 | 276 | 1,184 | 2,234 | 5,980 |
| Q2 FY27 | 184 | 3,785 | 1,125 | 1,011 | 2,291 | 358 | 1,352 | 2,105 | 6,106 |
Cash flow
| Year | Operating | Investing | Financing | Net |
|---|---|---|---|---|
| FY23 | 323 | -268 | -174 | -119 |
| FY24 | 359 | -233 | -224 | -98 |
| FY25 | 537 | -458 | -161 | -82 |
| FY26 | 546 | -318 | -273 | -45 |
Shareholding pattern
PromoterGovtFIIDIIPublicOthers
Q3'25
Q4'25
Q1'26
Q2'26
Q3'26
Q4'26
Q1'27
Q2'27
Ratios
Last 4 years, with trend
| Ratio | FY23 | FY24 | FY25 | FY26 | Trend |
|---|---|---|---|---|---|
| Debtor Days | 39 | 37 | 44 | 41 | |
| Inventory Days | 40 | 70 | 26 | 43 | |
| Payable Days | 41 | 34 | 58 | 31 | |
| Cash Conversion Cycle | 38 | 73 | 12 | 53 | |
| Working Capital Days | 35 | 83 | 12 | 50 | |
| ROCE % | 14.7 | 15.6 | 15.4 | 16.9 | |
| ROE % | 12.6 | 13.1 | 14 | 14.6 | |
| OPM % | 20.9 | 21.6 | 21.8 | 21.2 |
Statement figures on this page are illustrative demo data until this company is scraped by the data pipeline. For educational purposes only. Not investment advice.